Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Ulcerative Colitis in 12 Major Markets
Ulcerative Colitis (UC) is an inflammatory bowel disease (IBD) causing chronic inflammation in the colon, and is treated as an autoimmune disease. While sharing some features with Crohn's disease, UC is an intermittent disease with periods of symptoms interspersed with asymptomatic periods (generally induced by response to treatment). The disease involves the rectum up to the colon and is classified according to length of colon affected.
This report provides the current prevalent population for Ulcerative Colitis across 12 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Russia, Brazil, Japan, China, India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Ulcerative Colitis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for Ulcerative Colitis include:
• Anaemia
• Gastritis
• Colorectal cancer
• Osteoporosis
• Complications from surgery
• Pouchitis
• Toxic megacolon
• Extra-intestinal features (e.g. primary sclerosing cholangitis, erythema nodosum)
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Reason to buy
• Able to quantify patient populations in global Ulcerative Colitis’s market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the prevalence of the subdivided types of Ulcerative Colitis and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Provide a level of understanding on the impact from specific co-morbid conditions on Ulcerative Colitis’s prevalent population.
• Identify sub-populations within Ulcerative Colitis which require treatment.
• Gain an understanding of the specific markets that have the largest number of Ulcerative Colitis patients.
Ulcerative Colitis
Table of Contents
• LIST OF TABLES AND FIGURES
• INTRODUCTION
• CAUSE OF THE DISEASE
• RISK FACTORS & PREVENTION
• DIAGNOSIS OF THE DISEASE
• VARIATION BY GEOGRAPHY/ETHNICITY
• DISEASE PROGNOSIS & CLINICAL COURSE
• KEY COMORBID CONDITIONS / FEATURES ASSOCIATED WITH THE DISEASE
• METHODOLOGY FOR QUANTIFICATION OF PATIENT NUMBERS
• TOP-LINE PREVALENCE FOR ULCERATIVE COLITIS
• FEATURES OF ULCERATIVE COLITIS PATIENTS
o Severity and Type of Involvement in UC
o Contributing Factors to UC Development
• ASSOCIATED CONDITIONS OF ULCERATIVE COLITIS
o Skeletal Associated Conditions
o Dermatological Associated Conditions
o Digestive System Related Conditions
o Haematological Conditions and Biomarkers
• ABBREVIATIONS USED IN THE REPORT
• OTHER BLACK SWAN ANALYSIS PUBLICATIONS
• BLACK SWAN ANALYSIS ONLINE PATIENT-BASED DATABASES
• PATIENT-BASED OFFERING
• ONLINE PRICING DATA & PLATFORMS
• REFERENCES
• APPENDIX
List of Tables
• Table 1. Severity index for adult UC patients
• Table 2. Prevalence of Ulcerative Colitis, total (000s)
• Table 3. Prevalence of Ulcerative Colitis, males (000s)
• Table 4. Prevalence of Ulcerative Colitis, females (000s)
• Table 5. Extent of involvement at diagnosis in Ulcerative Colitis patients, total (000s)
• Table 6. Severity of Ulcerative Colitis at diagnosis in patients, total (000s)
• Table 7. Smoking status of Ulcerative Colitis patients, total (000s)
• Table 8. Ulcerative Colitis patients with family history of UC, total (000s)
• Table 9. Prevalence of osteoporosis in Ulcerative Colitis patients, total (000s)
• Table 10. Prevalence of peripheral arthritis in Ulcerative Colitis patients, total (000s)
• Table 11. Prevalence of ankylosing spondylitis in Ulcerative Colitis patients, total (000s)
• Table 12. Prevalence of oral ulcerations in Ulcerative Colitis patients, total (000s)
• Table 13. Prevalence of pyoderma gangrenosum in Ulcerative Colitis patients, total (000s)
• Table 14. Prevalence of primary sclerosing cholangitis in Ulcerative Colitis patients, total (000s)
• Table 15. Prevalence of gastritis in Ulcerative Colitis patients, total (000s)
• Table 16. Type of gastritis in Ulcerative Colitis patients, total (000s)
• Table 17. Prevalence of anaemia in Ulcerative Colitis patients, total (000s)
• Table 18. Prevalence of elevated CRP in Ulcerative Colitis patients, total (000s)
• Table 19. Prevalence of elevated ESR in Ulcerative Colitis patients, total (000s)
• Table 20. Abbreviations and Acronyms used in the report
• Table 21. USA Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
• Table 22. USA Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
• Table 23. Canada Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
• Table 24. Canada Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
• Table 25. France Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
• Table 26. France Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
• Table 25. Germany Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
• Table 26. Germany Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
• Table 27. Italy Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
• Table 28. Italy Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
• Table 29. Spain Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
• Table 30. Spain Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
• Table 31. United Kingdom Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
• Table 32. United Kingdom Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
• Table 31. Russia Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
• Table 32. Russia Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
• Table 33. Brazil Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
• Table 34. Brazil Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
• Table 35. Japan Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
• Table 36. Japan Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
• Table 35. China Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
• Table 36. China Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
• Table 35. India Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
• Table 36. India Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
